Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001782421 | SCV002127370 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-12-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MCCC2 protein function. This missense change has been observed in individual(s) with 3 methylcrotonyl-CoA carboxylase deficiency (PMID: 16835865). This variant is present in population databases (rs748028684, gnomAD 0.002%). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 101 of the MCCC2 protein (p.Ser101Phe). |
Baylor Genetics | RCV001782421 | SCV004194382 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-02-07 | criteria provided, single submitter | clinical testing |